Anika Therapeutics, Inc. Annual Return On Assets in % from 2012 to 2023

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Anika Therapeutics, Inc. quarterly/annual Return On Assets history and growth rate from 2012 to 2023.
  • Anika Therapeutics, Inc. Return On Assets for the quarter ending September 30, 2024 was -37.9 %, a 419% decline year-over-year.
  • Anika Therapeutics, Inc. annual Return On Assets for 2023 was -26.1 %, a 512% decline from 2022.
  • Anika Therapeutics, Inc. annual Return On Assets for 2022 was -4.27 %, a 468% decline from 2021.
  • Anika Therapeutics, Inc. annual Return On Assets for 2021 was 1.16 %.
Return On Assets, Annual (%)
Return On Assets, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -26.1 -21.8 -512% Jan 1, 2023 Dec 31, 2023
2022 -4.27 -5.43 -468% Jan 1, 2022 Dec 31, 2022
2021 1.16 +7.08 Jan 1, 2021 Dec 31, 2021
2020 -5.92 -14.7 -168% Jan 1, 2020 Dec 31, 2020
2019 8.74 +1.92 +28.2% Jan 1, 2019 Dec 31, 2019
2018 6.82 -5.09 -42.7% Jan 1, 2018 Dec 31, 2018
2017 11.9 -2.42 -16.9% Jan 1, 2017 Dec 31, 2017
2016 14.3 +0.1 +0.7% Jan 1, 2016 Dec 31, 2016
2015 14.2 -6.72 -32.1% Jan 1, 2015 Dec 31, 2015
2014 21 +7.3 +53.5% Jan 1, 2014 Dec 31, 2014
2013 13.7 +5.05 +58.7% Jan 1, 2013 Dec 31, 2013
2012 8.6 Jan 1, 2012 Dec 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.